Skip to content

Ketamine Effect After Laparoscopic Gastric Reduction: A Randomized, Double-Blinded, Placebo Controlled Study

Ketamine Effect on Recovery and Respiratory Outcomes After Laparoscopic Gastric Reduction: A Randomized, Double-Blinded, Placebo Controlled Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01997515
Enrollment
80
Registered
2013-11-28
Start date
2013-11-30
Completion date
2019-08-22
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxia, Obesity, Pain

Keywords

Quality of Recovery 40 Questionaire, Pain, Hypoxia, Gastric Surgery, Obesity, Ketamine

Brief summary

Laparoscopic surgery for gastric reduction is frequently associated with high levels of postoperative pain. Postoperative pain is very often treated with opioids. However large doses of opioids can result in respiratory depression with hypoxemia especially in high risk patients with obstructive sleep apnea. since a large group of patients undergoing surgery for gastric reduction surgery also have obstructive sleep apnea, it is expected that these patients are also at high risk for postoperative respiratory depression and hypoxemia. Intraoperative ketamine has been used as an effective multimodal agent to reduce postoperative pain. However, ketamine alone has not been examined to improve postoperative pain outcomes in patients undergoing gastric reduction surgery. More importantly, it is unknown if the use of intraoperative ketamine can lead to better overall quality of recovery in the same patient population. In addition, ketamine has been shown to improve ventilation but it remains to be determined if the intraoperative use of ketamine will result in less postoperative hypoxemic events. The main objective of the current investigation is to examine the effect of intraoperative ketamine on postoperative quality of recovery after gastric reduction surgery. The investigators hypothesize that subjects receiving ketamine will have a greater global quality of recovery score than the ones receiving saline.

Interventions

DRUGKetamine

Group K (ketamine) will receive 0.5mg /kg of ketamine bolus followed by an infusion of 0.5 mg/kg/hour of ketamine throughout the intraoperative period (Adjusted body weight).

DRUGplacebo

Group P (placebo) will receive the same amount of saline.

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-64 * surgery: laparoscopic gastric reduction (gastric sleeve or gastric bypass) * ASA physical status classification I, II, III * Body Mass Index \>35kg/m2 * Fluent in English

Exclusion criteria

* History of allergy to protocol medications * History of chronic opioid use * Pregnant patients * Drop out: Conversion to an open surgical route, patient or surgeon request.

Design outcomes

Primary

MeasureTime frameDescription
Quality of Recovery 4024 hoursScores on QOR (quality of recovery) 40 questionnaire. The QoR-40 score, which ranges from 40 to 200, representing very poor (low scores) to outstanding quality of recovery (high scores), respectively.

Secondary

MeasureTime frameDescription
Postoperative Opioid Consumption24 hoursTotal number of opioids (morphine equivalents) consumed 24 hours after surgery
Postoperative Pain Scores24 hoursParticipants pain scores will be recorded at 24 hours after surgery. Pain scores range from 0 (no pain) to 10 (worst pain imaginable).
Length of Hospital StayUp to 2 weeksThe subjects length of hospital stay will be recorded. Length of stay is defined as day of surgery to date of discharge from the hospital which may be up to 2 weeks..

Countries

United States

Participant flow

Participants by arm

ArmCount
Group K (Ketamine)
Group K (ketamine) will receive 0.5mg /kg of ketamine bolus followed by an infusion of 0.5 mg/kg/hour of ketamine throughout the intraoperative period (Adjusted body weight).
40
Group P (Placebo)
Group P (placebo) will receive the same amount of saline.
40
Total80

Baseline characteristics

CharacteristicGroup K (Ketamine)Group P (Placebo)Total
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
40 Participants40 Participants80 Participants
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
35 Participants27 Participants62 Participants
Sex: Female, Male
Male
5 Participants13 Participants18 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 400 / 40
other
Total, other adverse events
0 / 400 / 40
serious
Total, serious adverse events
0 / 400 / 40

Outcome results

Primary

Quality of Recovery 40

Scores on QOR (quality of recovery) 40 questionnaire. The QoR-40 score, which ranges from 40 to 200, representing very poor (low scores) to outstanding quality of recovery (high scores), respectively.

Time frame: 24 hours

ArmMeasureValue (MEDIAN)
Group K (Ketamine)Quality of Recovery 40170 score on a scale
Group P (Placebo)Quality of Recovery 40179 score on a scale
Secondary

Length of Hospital Stay

The subjects length of hospital stay will be recorded. Length of stay is defined as day of surgery to date of discharge from the hospital which may be up to 2 weeks..

Time frame: Up to 2 weeks

ArmMeasureValue (MEDIAN)
Group K (Ketamine)Length of Hospital Stay2.00 days
Group P (Placebo)Length of Hospital Stay2.00 days
Secondary

Postoperative Opioid Consumption

Total number of opioids (morphine equivalents) consumed 24 hours after surgery

Time frame: 24 hours

ArmMeasureValue (MEDIAN)
Group K (Ketamine)Postoperative Opioid Consumption4.45 Morphine Equivalents
Group P (Placebo)Postoperative Opioid Consumption6.3 Morphine Equivalents
Secondary

Postoperative Pain Scores

Participants pain scores will be recorded at 24 hours after surgery. Pain scores range from 0 (no pain) to 10 (worst pain imaginable).

Time frame: 24 hours

ArmMeasureValue (MEDIAN)
Group K (Ketamine)Postoperative Pain Scores4 score on a scale
Group P (Placebo)Postoperative Pain Scores4 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026